Skip to Content

WPI 3173 (Alendronate Sodium 70 mg)

Pill with imprint WPI 3173 is White, Capsule-shape and has been identified as Alendronate Sodium 70 mg. It is supplied by Watson Pharmaceuticals.

Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; aseptic necrosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 70 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3173

Alendronate sodium 70 mg WPI 3173
Alendronate sodium 70 mg WPI 3173
Alendronate sodium 70 mg WPI 3173

Alendronate Sodium

Imprint:
WPI 3173
Strength:
70 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
magnesium stearate
mannitol
microcrystalline cellulose
sodium starch glycolate type A potato
corn starch
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide